Business Standard

HC seeks Singh brothers' reply on Daiichi's plea to sell Fortis trademark

Senior advocate Arvind Nigam, appearing for Daiichi, said this was a deliberate attempt to deprive the company from enjoying the fruits of the award in its favour

IHH Healthcare makes open offer for Fortis Malar at Rs 60 per share
Premium

The high court has directed for maintaining status quo on the Religare trademark till July 28

Press Trust of India New Delhi
The Delhi High Court has sought response of former Ranbaxy promoters Malvinder Mohan Singh and Shivinder Mohan Singh on a plea by Daiichi Sankyo seeking to attach and sell trademarks of Fortis and Religare and recover the amount due to the Japanese company.

The high court has directed for maintaining status quo on the Religare trademark till July 28.

The high court has been hearing the petition filed by Japanese pharma major Daiichi Sankyo seeking execution of Rs 3,500 crore Singapore tribunal arbitral award passed in its favour and against the Singh brothers, former promoters of Fortis Healthcare, in April

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in